CervoMed Inc.
CervoMed Inc.（CRVO）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
crvo · 股价预测 · 7 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 7 位华尔街分析师
Buy
7 位分析师
共识
评级分布
12 个月目标价
High
$9.00
Consensus
$9.00
+209.3% upside
Low
$9.00
Median: $9 · Last Close: $2.91
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $2.79 | ↓ 3.99% |
1-day model range: $2.74–$2.85. Peak: $2.85 (-3.99%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -50.0% |
| 2028 | — | -62.5% |
| 2029 | — | -67.2% |
| 2030 | — | -69.2% |
| 2031 | — | -70.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · CRVO · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-22 | D. Boral Capital | Maintains | Buy→Buy |
| 2026-04-08 | D. Boral Capital | Maintains | Buy→Buy |
| 2026-03-19 | D. Boral Capital | Maintains | Buy→Buy |
| 2026-03-18 | Roth Capital | Maintains | Buy→Buy |
| 2026-03-18 | Chardan Capital | Maintains | Buy→Buy |
| 2026-03-16 | D. Boral Capital | Maintains | Buy→Buy |
| 2026-03-05 | Chardan Capital | Maintains | Buy→Buy |
| 2026-03-04 | D. Boral Capital | Maintains | Buy→Buy |
| 2026-02-18 | D. Boral Capital | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on CervoMed Inc. (CRVO) stock. Of the recent 46 rating actions, 4 were upgrades and 4 were downgrades. 7 analysts currently cover CRVO.
分析师推荐趋势
CRVO analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 3 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 81.7% YoY
Revenue Next Year
$1M
↑ 264.6% YoY
EPS This Year
$-2.70
EPS Next Year
$-2.46
↓ 8.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast CRVO EPS of $-2.70 for the current fiscal year, based on estimates from 5 analysts. The CRVO revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CRVO 股价预测由两类独立数据源支撑：来自 7 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CRVO 的共识目标价为 $9.00（+209.3% 上行空间），分析师共识为 Buy。
CRVO 的短期预测（明日）为 $2.79（-3.99%）。 CRVO 对 2030 年的预测区间为 $1–$1。
CervoMed Inc. 在 NASDAQ 上市，代码 CRVO。CRVO 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
CRVO 预测 · 8 个问题根据 7 位华尔街分析师，CRVO 的 12 个月平均目标价为 $9.00，最高 $9.00、最低 $9.00。若有图表，中位目标价可在上方查看。相对当前价 $2.91，隐含约 +209.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.